Avantor, Inc. (AVTR)

US — Basic Materials Sector
Peers: ASH  FUL  ESI  BCPC  AXTA  AVNT  KWR  CBT  SXT  IOSP  MTX  ODC  ECVT 

Automate Your Wheel Strategy on AVTR

With Tiblio's Option Bot, you can configure your own wheel strategy including AVTR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol AVTR
  • Rev/Share 9.7811
  • Book/Share 9.2236
  • PB 1.3964
  • Debt/Equity 0.6749
  • CurrentRatio 0.9763
  • ROIC 0.077

 

  • MktCap 8780798320.0
  • FreeCF/Share 0.8157
  • PFCF 15.7956
  • PE 12.7695
  • Debt/Assets 0.332
  • DivYield 0
  • ROE 0.1151

 

  • Rating A-
  • Score 4
  • Recommendation Buy
  • P/E Score 2
  • DCF Score 5
  • P/B Score 3
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade AVTR Jefferies Buy Hold -- -- Aug. 1, 2025
Downgrade AVTR Goldman Buy Neutral -- $14 April 29, 2025
Downgrade AVTR TD Cowen Buy Hold -- $15.5 April 28, 2025
Downgrade AVTR Stifel Buy Hold -- $14 April 28, 2025
Downgrade AVTR Morgan Stanley Overweight Equal Weight -- -- April 28, 2025
Downgrade AVTR UBS Buy Neutral $29 $25 Jan. 17, 2025
Initiation AVTR Wells Fargo -- Overweight -- $30 Aug. 28, 2024

News

Avantor® Reiterates Shareholder Value Creation Focus
AVTR
Published: August 11, 2025 by: PRNewsWire
Sentiment: Neutral

Emmanuel Ligner, Seasoned Leader with Proven Track Record of Value Creation in Life Sciences, to Begin Role as CEO Next Week RADNOR, Pa. , Aug. 11, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today issued the following statement in response to the letter issued by Engine Capital: The Board of Directors is actively engaged in overseeing the setting and execution of the Company's strategy and is committed to always acting in the best interests of the Company and its shareholders.

Read More
image for news Avantor® Reiterates Shareholder Value Creation Focus
Activist investor Engine Capital urges Avantor to refresh board with new directors
AVTR
Published: August 11, 2025 by: Reuters
Sentiment: Neutral

Activist investor Engine Capital has urged medical equipment maker Avantor to refresh its board with new directors, a letter on Monday showed.

Read More
image for news Activist investor Engine Capital urges Avantor to refresh board with new directors
Engine Capital Sends Letter to Avantor's Board of Directors Regarding Opportunities to Improve Governance and Unlock Shareholder Value
AVTR
Published: August 11, 2025 by: Business Wire
Sentiment: Neutral

NEW YORK--(BUSINESS WIRE)--Engine Capital LP (together with its affiliates, “Engine” or “we”), which owns approximately 3% of the outstanding shares of Avantor, Inc. (NYSE: AVTR) (“Avantor” or the “Company”), today sent a letter to the Company's Board of Directors outlining several opportunities to close Avantor's significant valuation gap and unlock value for shareholders. The letter can be viewed and downloaded here. About Engine Capital Engine Capital LP is a value-oriented special situation.

Read More
image for news Engine Capital Sends Letter to Avantor's Board of Directors Regarding Opportunities to Improve Governance and Unlock Shareholder Value
Activist Investor to Push Avantor to Sell Itself
AVTR
Published: August 10, 2025 by: WSJ
Sentiment: Positive

Engine Capital has a roughly 3% stake in the life-sciences company.

Read More
image for news Activist Investor to Push Avantor to Sell Itself
AVTR Stock Declines as Q2 Earnings Miss Estimates, Revenues Down Y/Y
AVTR
Published: August 04, 2025 by: Zacks Investment Research
Sentiment: Negative

Avantor stock dips more than 15% as Q2 EPS missed estimates, revenue declines year over year and lowers full-year guidance.

Read More
image for news AVTR Stock Declines as Q2 Earnings Miss Estimates, Revenues Down Y/Y
Avantor, Inc. (AVTR) Q2 2025 Earnings Call Transcript
AVTR
Published: August 01, 2025 by: Seeking Alpha
Sentiment: Neutral

Avantor, Inc. (NYSE:AVTR ) Q2 2025 Earnings Conference Call August 1, 2025 8:00 AM ET Company Participants Allison K. Hosak - Senior VP of Global Communications & Brand Michael Stubblefield - President, CEO & Director R.

Read More
image for news Avantor, Inc. (AVTR) Q2 2025 Earnings Call Transcript
Avantor (AVTR) Reports Q2 Earnings: What Key Metrics Have to Say
AVTR
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Positive

Although the revenue and EPS for Avantor (AVTR) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Read More
image for news Avantor (AVTR) Reports Q2 Earnings: What Key Metrics Have to Say
Avantor Announces Emmanuel Ligner as Next President and CEO
AVTR
Published: July 21, 2025 by: PRNewsWire
Sentiment: Neutral

Seasoned Executive with Proven Track Record of Value Creation in Life Sciences RADNOR, Pa. , July 21, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that it has named Emmanuel Ligner, President and Chief Executive Officer, effective August 18, 2025.

Read More
image for news Avantor Announces Emmanuel Ligner as Next President and CEO
Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
AVTR
Published: May 16, 2025 by: PRNewsWire
Sentiment: Neutral

RADNOR, Pa. , May 16, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that Brent Jones, Executive Vice President and Chief Financial Officer, will be participating in a fireside chat at the RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 20, 2025 at approximately 8:00 a.m.

Read More
image for news Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference
Avantor Analysts Cut Their Forecasts After Q1 Results
AVTR
Published: April 28, 2025 by: Benzinga
Sentiment: Negative

Avantor Inc AVTR reported in-line earnings for its first quarter on Friday.

Read More
image for news Avantor Analysts Cut Their Forecasts After Q1 Results
Avantor, Inc. (AVTR) Q1 2025 Earnings Call Transcript
AVTR
Published: April 25, 2025 by: Seeking Alpha
Sentiment: Neutral

Avantor, Inc. (NYSE:AVTR ) Q1 2025 Earnings Call April 25, 2025 8:00 AM ET Company Participants Allison Hosak - SVP of Global Communications and Brand Michael Stubblefield - President and CEO R. Brent Jones - EVP and CFO Conference Call Participants Michael Ryskin - Bank of America Securities Vijay Kumar - Evercore ISI Rachel Vatnsdal - J.P.

Read More
image for news Avantor, Inc. (AVTR) Q1 2025 Earnings Call Transcript
Here's Why You Should Hold AVTR Stock in Your Portfolio for Now
AVTR
Published: March 27, 2025 by: Zacks Investment Research
Sentiment: Negative

Avantor is set for growth with a strong portfolio and solid fourth quarter results, but challenges like customer losses and forex volatility pose potential risks.

Read More
image for news Here's Why You Should Hold AVTR Stock in Your Portfolio for Now

About Avantor, Inc. (AVTR)

  • IPO Date 2019-05-17
  • Website https://www.avantorsciences.com
  • Industry Chemicals - Specialty
  • CEO Michael Stubblefield
  • Employees 13500

Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.